Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.

Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA.

Nature. 1996 Dec 5;384(6608):470-4.

PMID:
8945475
2.

D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.

Bartkova J, Rajpert-de Meyts E, Skakkebaek NE, Bartek J.

J Pathol. 1999 Apr;187(5):573-81.

PMID:
10398124
3.

Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.

Ajchenbaum F, Ando K, DeCaprio JA, Griffin JD.

J Biol Chem. 1993 Feb 25;268(6):4113-9.

5.

Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse.

Beumer TL, Roepers-Gajadien HL, Gademan IS, Kal HB, de Rooij DG.

Biol Reprod. 2000 Dec;63(6):1893-8.

PMID:
11090462
6.

Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.

Burns KH, Agno JE, Sicinski P, Matzuk MM.

Mol Endocrinol. 2003 Oct;17(10):2053-69. Epub 2003 Jul 10.

PMID:
12855747
8.

Transcriptional regulation of cyclin D2 by the PKA pathway and inducible cAMP early repressor in granulosa cells.

Muñiz LC, Yehia G, Mémin E, Ratnakar PV, Molina CA.

Biol Reprod. 2006 Aug;75(2):279-88. Epub 2006 Apr 19.

PMID:
16625003
9.
10.
13.

Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.

Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ.

Cancer Res. 2002 Jan 15;62(2):535-41.

14.

Proliferation-independent induction of macrophage cyclin D2, and repression of cyclin D1, by lipopolysaccharide.

Vadiveloo PK, Vairo G, Royston AK, Novak U, Hamilton JA.

J Biol Chem. 1998 Sep 4;273(36):23104-9.

15.

Mouse development and cell proliferation in the absence of D-cyclins.

Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P.

Cell. 2004 Aug 20;118(4):477-91.

16.

Regulation of cell cycle entry and G1 progression by CSF-1.

Roussel MF.

Mol Reprod Dev. 1997 Jan;46(1):11-8. Review.

PMID:
8981358
17.

The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells.

Jirawatnotai S, Moons DS, Stocco CO, Franks R, Hales DB, Gibori G, Kiyokawa H.

J Biol Chem. 2003 May 9;278(19):17021-7. Epub 2003 Feb 27.

18.

Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.

Ma Y, Feng Q, Sekula D, Diehl JA, Freemantle SJ, Dmitrovsky E.

Cancer Res. 2005 Jul 15;65(14):6476-83.

19.

Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.

Yu Q, Ciemerych MA, Sicinski P.

Oncogene. 2005 Oct 27;24(47):7114-9.

PMID:
16103884
20.

FSH-regulated gene expression profiles in ovarian tumours and normal ovaries.

Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ.

Mol Hum Reprod. 2002 May;8(5):426-33.

PMID:
11994539

Supplemental Content

Support Center